RBDCOV EU | HORIZON EUROPE PROJECT

January 20, 2022

At Asphalion we are proud to announce that we are Regulatory partners of the consortium working on the RBDCOV_EU project 🦠💉🔬!!

RBD Dimer recombinant protein vaccine against SARSCoV2 (RBDCOV) is a new Horizon Europe project led by the biotech pharmaceutical company HIPRA and funded by the Horizon Europe programme which aims at testing the efficacy, tolerability, and safety of the vaccine in children (including adolescents) and immunocompromised people against the different variants of COVID-19 using a recombinant protein. The trials will last 2.5 years.

To carry out this project, HIPRA will work with an international consortium including companies and institutions from five European countries: Spain, United Kingdom, Italy, Germany and Turkey

Have a look here for further information:

PRESS RELEASE

 

 

 

Search News & Events

  • Filter by category

Share

Related news and events

HORIZON | siNPAIN meeting in Reykjavík

The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for different stages of osteoarthritis.  All siNPAIN partners are working hard to develop efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.

EVENT | Symposium AEFI 2024

¡Mañana arranca el 42º Symposium de AEFI! No olvidéis visitarnos en la mesa 6 para conocer de todos los servicios que ofrecemos. Os recordamos los

PRAGMATIL | First annual progress meeting

The partners of the PragmaTIL consortium have gathered in Barcelona to hold its first annual meeting. Asphalion’s experts Montse Domingo and Nuria García Pazos attended

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting